PTHS$10.77-6.51%
Pelthos Therapeutics Inc.
Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: USExchange: NYSE
Mkt Cap:$42.35M
Float & O/S:
Inst Own:
DilutionScan read 33 of Pelthos Therapeutics Inc.'s SEC filings and found 4 warrant series, 5 convertibles, 1 equity line, 2 shelf registrations and 2 completed offerings on file for PTHS. Analysis updated Nov 1, 2026.